Macrophages directly mediate diabetic renal injury

Area of Science:

• Nephrology
• Immunology
• Diabetology

Background:

• Monocyte/macrophage infiltration correlates with diabetic nephropathy (DN) progression.
• The precise role of macrophages in direct podocyte injury within DN remains unclear.
• Understanding macrophage involvement is crucial for developing targeted DN therapies.

Purpose of the Study:

• To investigate the direct role of macrophages in podocyte injury and the development of DN.
• To determine if macrophage depletion can ameliorate DN-related kidney damage.
• To explore the in vitro interaction between podocytes and different macrophage subsets.

Main Methods:

• Utilized CD11b-DTR mice treated with diphtheria toxin (DT) to deplete macrophages post-streptozotocin-induced diabetes.
• Employed bone marrow chimeric mice (CD11b-DTR→ C57BL6/J) to confirm findings.
• Conducted in vitro experiments with high-glucose cultured podocytes and M1/M2 macrophages.

Main Results:

• Macrophage depletion in diabetic mice significantly reduced albuminuria, kidney macrophage infiltration, and glomerular damage.
• Preserved nephrin and podocin expression in kidneys of diabetic mice with macrophage depletion.
• In vitro, high glucose increased podocyte-induced macrophage migration, and M1 macrophages increased podocyte permeability.

Conclusions:

• Macrophages, particularly the M1 subset, directly contribute to kidney injury in DN by damaging podocytes.
• Macrophage depletion offers a potential therapeutic strategy for DN by protecting podocyte integrity.
• Targeting macrophage-driven inflammation presents a novel therapeutic avenue for diabetic nephropathy.